Login Register Cart 0
Generic placeholder image

Current Cancer Therapy Reviews

Editor-in-Chief

ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

The Pathogenic Roles of lncRNAs in Glioma

Author(s): Arya Moftakhar, Seyed Esmaeil Khoshnam and Maryam Farzaneh*

Volume 20, Issue 1, 2024

Published on: 22 May, 2023

Page: [12 - 17] Pages: 6

DOI: 10.2174/1573394719666230316112549

Price: $65

Abstract

Brain cancers or intracranial cancers are among the deadliest cancers in the world. The presence of tumorigenic cancer cells in the brain and induction of poor prognosis may impact the survival/death balance. Glioma is a type of brain tumor that begins in the glial tissue. Recently, it has been reported that long non-coding RNAs (lncRNAs) with at least 200 nucleotides in length by targeting DNAs, RNAs, and proteins play essential roles in several biological processes, including growth, differentiation, and development. Recently, lncRNAs was reported to contribute to the tumorigenesis of glioma by targeting miRNAs, other ncRNAs, and mRNAs. In this review, we focused on the functional roles of lnRNAs in glioma.

Keywords: LncRNAs, brain cancer, biomarker, glioma, pathogenesis, signaling pathways.

« Previous Next »
[1]
Mazur J, Roy K, Kanwar JR. Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine 2018; 13(1): 105-37.
[http://dx.doi.org/10.2217/nnm-2017-0286] [PMID: 29161215]
[2]
Quader S, Kataoka K, Cabral H. Nanomedicine for brain cancer. Adv Drug Deliv Rev 2022; 182: 114115.
[http://dx.doi.org/10.1016/j.addr.2022.114115] [PMID: 35077821]
[3]
Riano I, Bravo P, Bravo LE, Garcia LS, Collazos P, Carrascal E. Incidence, mortality, and survival trends of primary CNS Tumors in Cali, Colombia, From 1962 to 2019. JCO Glob Oncol 2020; 6(6): 1712-20.
[http://dx.doi.org/10.1200/GO.20.00368] [PMID: 33156716]
[4]
Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet 2018; 392(10145): 432-46.
[http://dx.doi.org/10.1016/S0140-6736(18)30990-5] [PMID: 30060998]
[5]
Goenka A, Tiek D, Song X, Huang T, Hu B, Cheng SY. The many facets of therapy resistance and tumor recurrence in glioblastoma. Cells 2021; 10(3): 484.
[http://dx.doi.org/10.3390/cells10030484] [PMID: 33668200]
[6]
Xu WW, Jin J, Wu X, Ren QL, Farzaneh M. MALAT1-related signaling pathways in colorectal cancer. Cancer Cell Int 2022; 22(1): 126.
[http://dx.doi.org/10.1186/s12935-022-02540-y] [PMID: 35305641]
[7]
Farzaneh M, Kuchaki Z, Rashid Sheykhahmad F, et al. Emerging roles of JMJD3 in cancer. Clin Transl Oncol 2022; 24(7): 1238-49.
[8]
Anbiyaiee A, Ramazii M, Bajestani SS, et al. The function of LncRNA-ATB in cancer. Clin Transl Oncol 2022; 25(1): 1-9.
[http://dx.doi.org/10.1007/s12094-022-02848-1] [PMID: 35597865]
[9]
Pruitt AA. Central nervous system infections in cancer patients. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. 2022; pp. 195-222.
[http://dx.doi.org/10.1016/B978-0-12-821976-8.00014-1]
[10]
Kim SH, Lim KH, Yang S, Joo JY. Long non-coding RNAs in brain tumors: Roles and potential as therapeutic targets. J Hematol Oncol 2021; 14(1): 77.
[http://dx.doi.org/10.1186/s13045-021-01088-0] [PMID: 33980320]
[11]
Zhang M, Yu X, Zhang Q, Sun Z, He Y, Guo W. MIR4435-2HG: A newly proposed lncRNA in human cancer. Biomed Pharmacother 2022; 150: 112971.
[http://dx.doi.org/10.1016/j.biopha.2022.112971] [PMID: 35447550]
[12]
Guo C, Qi Y, Qu J, Gai L, Shi Y, Yuan C. Pathophysiological Functions of the lncRNA TUG1. Curr Pharm Des 2020; 26(6): 688-700.
[http://dx.doi.org/10.2174/1381612826666191227154009] [PMID: 31880241]
[13]
Latowska J, Grabowska A, Zarębska Ż, Kuczyński K, Kuczyńska B, Rolle K. Non-coding RNAs in brain tumors, the contribution of lncRNAs, circRNAs, and snoRNAs to cancer development—their diagnostic and therapeutic potential. Int J Mol Sci 2020; 21(19): 7001.
[http://dx.doi.org/10.3390/ijms21197001] [PMID: 32977537]
[14]
He Y, Nan H, Yan L, et al. Long non coding RNA MIR22HG inhibits glioma progression by downregulating microRNA 9/CPEB3. Oncol Lett 2020; 21(2): 157.
[http://dx.doi.org/10.3892/ol.2020.12418] [PMID: 33552275]
[15]
Semaan L, Zeng Q, Lu Y, et al. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs. Oncotarget 2021; 12(3): 185-98.
[http://dx.doi.org/10.18632/oncotarget.27879] [PMID: 33613846]
[16]
Dang Y, Wei X, Xue L, Wen F, Gu J, Zheng H. Long Non-coding RNA in Glioma: Target miRNA and Signaling Pathways. Clin Lab 2018; 64(06/2018): 887-94.
[http://dx.doi.org/10.7754/Clin.Lab.2018.180107] [PMID: 29945317]
[17]
Yang X, Tao H, Wang C, Chen W, Hua F, Qian H. lncRNA ATB promotes stemness maintenance in colorectal cancer by regulating transcriptional activity of the β catenin pathway. Exp Ther Med 2020; 19(4): 3097-103.
[http://dx.doi.org/10.3892/etm.2020.8558] [PMID: 32256798]
[18]
Liu P, Huang X, Wu H, Yin G, Shen L. LncRNA‐H19 gene plays a significant role in regulating glioma cell function. Mol Genet Genomic Med 2021; 9(10): e1480.
[http://dx.doi.org/10.1002/mgg3.1480] [PMID: 34477331]
[19]
Zhao W, Lin X, Han H, et al. Long noncoding RNA H19 contributes to the proliferation and autophagy of glioma cells through mTOR/ULK1 pathway. Neuroreport 2021; Publish Ahead of Print (5): 352-8.
[http://dx.doi.org/10.1097/WNR.0000000000001602] [PMID: 33661803]
[20]
Chen X, Li Y, Zuo C, et al. Long Non-coding RNA H19 Regulates Glioma Cell Growth and Metastasis via miR-200a-Mediated CDK6 and ZEB1 Expression. Front Oncol 2021; 11: 757650.
[http://dx.doi.org/10.3389/fonc.2021.757650] [PMID: 34796112]
[21]
Deng D, Mo Y, Xue L, Shao N, Cao J. Long non coding RNA SUMO1P3 promotes tumour progression by regulating cell proliferation and invasion in glioma. Exp Ther Med 2021; 21(5): 491.
[http://dx.doi.org/10.3892/etm.2021.9922] [PMID: 33791000]
[22]
Lou JY, Luo J, Yang SC, et al. Long non-coding RNA SUMO1P3 promotes glioma progression via the Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci 2020; 24(18): 9571-80.
[PMID: 33015800]
[23]
Wan Y, Liang F, Wei M, Liu Y. Retracted article: Long non-coding RNA LINC00525 regulates the proliferation and epithelial to mesenchymal transition of human glioma cells by sponging miR-338-3p. AMB Express 2020; 10(1): 156.
[http://dx.doi.org/10.1186/s13568-020-01094-4] [PMID: 32857271]
[24]
Zhang Q, Wang G, Xu L, Yao Z, Song L. Long non-coding RNA LINC00473 promotes glioma cells proliferation and invasion by impairing miR-637/CDK6 axis. Artif Cells Nanomed Biotechnol 2019; 47(1): 3896-903.
[http://dx.doi.org/10.1080/21691401.2019.1671431] [PMID: 31561732]
[25]
Wang X, Li XD, Fu Z, Zhou Y, Huang X, Jiang X. Long non coding RNA LINC00473/miR 195 5p promotes glioma progression via YAP1 TEAD1 Hippo signaling. Int J Oncol 2020; 56(2): 508-21.
[PMID: 31894297]
[26]
Shi J, Zhang Y, Qin B, Wang Y, Zhu X. Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma. J Exp Clin Cancer Res 2019; 38(1): 395.
[http://dx.doi.org/10.1186/s13046-019-1390-x] [PMID: 31492194]
[27]
Li B, Zhao H, Song J, Wang F, Chen M. LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis. Hum Cell 2020; 33(1): 159-74.
[http://dx.doi.org/10.1007/s13577-019-00281-1] [PMID: 31713817]
[28]
Li Q, Lu J, Xia J, Wen M, Wang C. Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochem Biophys Res Commun 2019; 512(3): 558-63.
[http://dx.doi.org/10.1016/j.bbrc.2019.03.124] [PMID: 30914197]
[29]
Li H, Xue Y, Ma J, et al. SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop. J Exp Clin Cancer Res 2019; 38(1): 59.
[http://dx.doi.org/10.1186/s13046-019-1063-9] [PMID: 30728054]
[30]
Mi S, Du J, Liu J, et al. FtMt promotes glioma tumorigenesis and angiogenesis via lncRNA SNHG1/miR-9-5p axis. Cell Signal 2020; 75: 109749.
[http://dx.doi.org/10.1016/j.cellsig.2020.109749] [PMID: 32858123]
[31]
Liu L, Shi Y, Shi J, et al. The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression. Cell Death Dis 2019; 10(6): 463.
[http://dx.doi.org/10.1038/s41419-019-1698-7] [PMID: 31189920]
[32]
Guo X, Zheng J, Yu MJ, Piao HZ, Zhao HY. Long noncoding RNA SNHG3 promotes glioma tumorigenesis by sponging miR‐485‐5p to upregulate LMX1B expression. Kaohsiung J Med Sci 2021; 37(10): 851-62.
[http://dx.doi.org/10.1002/kjm2.12411] [PMID: 34153159]
[33]
Zhang X, Zheng W, Jiang W, Lin R, Xing C. Long non-coding RNA SNHG3 accelerates progression in glioma by modulating miR-384/HDGF axis. Open Life Sci 2020; 15(1): 654-64.
[http://dx.doi.org/10.1515/biol-2020-0066] [PMID: 33817254]
[34]
Meng X, Deng Y, Lv Z, et al. LncRNA SNHG5 Promotes Proliferation of Glioma by Regulating miR-205-5p/ZEB2 Axis. OncoTargets Ther 2019; 12: 11487-96.
[http://dx.doi.org/10.2147/OTT.S228439] [PMID: 31920337]
[35]
Hu X, Hong Y, Shang C. Knockdown of long non-coding RNA SNHG5 inhibits malignant cellular phenotypes of glioma via Wnt/CTNNB1 signaling pathway. J Cancer 2019; 10(5): 1333-40.
[http://dx.doi.org/10.7150/jca.29517] [PMID: 30854143]
[36]
Deng Y, Cheng L, Lv Z, Zhu H, Meng X. lncRNA SNHG7 promotes cell proliferation in glioma by acting as a competing endogenous RNA and sponging miR 138 5p to regulate EZH2 expression. Oncol Lett 2021; 22(1): 565.
[http://dx.doi.org/10.3892/ol.2021.12826] [PMID: 34113393]
[37]
Cheng G, Zheng J, Wang L. LncRNA SNHG7 promotes glioma cells viability, migration and invasion by regulating miR-342-3p/AKT2 axis. Int J Neurosci 2021; 131(12): 1190-202.
[http://dx.doi.org/10.1080/00207454.2020.1790556] [PMID: 32628059]
[38]
Geng YB, Xu C, Wang Y, Zhang LW. Long non-coding RNA SNHG11 promotes cell proliferation, invasion and migration in glioma by targeting miR-154-5p. Eur Rev Med Pharmacol Sci 2020; 24(9): 4901-8.
[PMID: 32432753]
[39]
Lei W, Wang ZL, Feng HJ, Lin XD, Li CZ, Fan D. Long non-coding RNA SNHG12promotes the proliferation and migration of glioma cells by binding to HuR. Int J Oncol 2018; 53(3): 1374-84.
[http://dx.doi.org/10.3892/ijo.2018.4478] [PMID: 30015836]
[40]
Sun Y, Liu J, Chu L, et al. Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101-3p/FOXP1 axis. Gene 2018; 676: 315-21.
[http://dx.doi.org/10.1016/j.gene.2018.08.034] [PMID: 30098431]
[41]
Liu X, Zheng J, Xue Y, et al. Inhibition of TDP43-Mediated SNHG12-miR-195-SOX5 feedback loop impeded malignant biological behaviors of glioma cells. Mol Ther Nucleic Acids 2018; 10: 142-58.
[http://dx.doi.org/10.1016/j.omtn.2017.12.001] [PMID: 29499929]
[42]
Ge BH, Li GC. Long non‐coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR‐23b‐3p/ZHX1 axis. J Gene Med 2020; 22(11): e3247.
[http://dx.doi.org/10.1002/jgm.3247] [PMID: 32602607]
[43]
Li H, Li T, Huang D, Zhang P. Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway. Cancer Cell Int 2020; 20(1): 29.
[http://dx.doi.org/10.1186/s12935-019-1088-3] [PMID: 32009853]
[44]
Zhang J, Li Y, Liu Y, et al. Long non coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA 324 5p and upregulating KCTD20 expression. Oncol Rep 2021; 46(1): 125.
[http://dx.doi.org/10.3892/or.2021.8076] [PMID: 33982764]
[45]
Li Y, Wang X, Zhao Z, Shang J, Li G, Zhang R. LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1. Biosci Rep 2021; 41(7): BSR20200767.
[http://dx.doi.org/10.1042/BSR20200767] [PMID: 33393590]
[46]
Liu D, Zou Z, Li G, Pan P, Liang G. Long noncoding RNA NEAT1 suppresses proliferation and promotes apoptosis of glioma Cells via Downregulating MiR-92b. Cancer Contr 2020; 27(1)
[http://dx.doi.org/10.1177/1073274819897977] [PMID: 31933377]
[47]
Huang T, Chen Y, Zeng Y, et al. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway. BMC Cancer 2021; 21(1): 844.
[http://dx.doi.org/10.1186/s12885-021-08465-5] [PMID: 34294084]
[48]
He L, Yang H, Zhu XL, Zhang Y, Lv K. Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/β-catenin signaling pathways. Brain Res Bull 2021; 176: 112-20.
[http://dx.doi.org/10.1016/j.brainresbull.2021.08.011] [PMID: 34474120]
[49]
Sheng J, He X, Yu W, et al. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma. Cancer Lett 2021; 503: 54-68.
[http://dx.doi.org/10.1016/j.canlet.2020.12.039] [PMID: 33476649]
[50]
Zheng D, Chen D, Lin F, et al. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis. Cell Cycle 2020; 19(13): 1621-31.
[http://dx.doi.org/10.1080/15384101.2020.1762037] [PMID: 32420808]
[51]
Pan T, Xue M. LncRNA-NNT-AS1 contributes to the progression of glioma by miR-582-5p/EZH2 axis. Cytotechnology 2021; 73(3): 473-82.
[http://dx.doi.org/10.1007/s10616-021-00471-6] [PMID: 34149178]
[52]
Chen ZH, Hu HK, Zhang CR, et al. Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells. Am J Transl Res 2016; 8(10): 4106-19.
[PMID: 27829996]
[53]
Zhu XP, Pan SA, Chu Z, Zhou YX, Huang YK, Han DQ. LncRNA GAS5 regulates epithelial-mesenchymal transition and viability of glioma cells by targeting microRNA-106b and regulating PTEN expression. Neurosci Res 2021; 170: 32-40.
[http://dx.doi.org/10.1016/j.neures.2020.08.009] [PMID: 32991951]
[54]
Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway. Neurotherapeutics 2018; 15(4): 1139-57.
[http://dx.doi.org/10.1007/s13311-018-0649-9] [PMID: 30120709]
[55]
Bi Y, Ji J, Zhou Y. LncRNA-PVT1 indicates a poor prognosis and promotes angiogenesis via activating the HNF1B/EMT axis in glioma. J Cancer 2021; 12(19): 5732-44.
[http://dx.doi.org/10.7150/jca.60257] [PMID: 34475987]
[56]
Gong R, Li ZQ, Fu K, Ma C, Wang W, Chen JC. Long Non-coding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma. Exp Neurobiol 2021; 30(3): 244-55.
[http://dx.doi.org/10.5607/en20060] [PMID: 34230224]
[57]
Luo C, Quan Z, Zhong B, et al. lncRNA XIST promotes glioma proliferation and metastasis through miR 133a/SOX4. Exp Ther Med 2020; 19(3): 1641-8.
[http://dx.doi.org/10.3892/etm.2020.8426] [PMID: 32104215]
[58]
Wang YP, Li HQ, Chen JX, et al. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis. Eur Rev Med Pharmacol Sci 2020; 24(6): 3190-203.
[PMID: 32271437]
[59]
Huang W, Shi Y, Han B, et al. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR‐106b-5p/TUSC2 axis. Hum Cell 2020; 33(2): 416-26.
[http://dx.doi.org/10.1007/s13577-020-00331-z] [PMID: 32072565]

Rights & Permissions Print Cite
Article Metrics
7
2
© 2024 Bentham Science Publishers | Privacy Policy